
Buyers flee Japanese bonds as political, fiscal risks rise
In a sign of how nervous markets are, the Ministry of Finance's first sale of super-long government debt since a bruising electoral defeat for Prime Minister Shigeru Ishiba logged the weakest demand in almost 14 years.
In a whirlwind day of news, the United States and Japan announced a trade deal, speculation swirled that Ishiba planned to resign, and a Bank of Japan (BOJ) official warned of an economic slowdown.
The 10-year JGB yield jumped as much as 10 basis points (bps) to 1.6%, marking its biggest move in months and the highest level since October 2008.
Super-long term JGB yields hit record highs in May and are back near those levels as concerns mount over Japan's precarious finances.
"We're seeing a possible buyers' strike playing through," said Chris Weston, head of research at broker Pepperstone.
"Inflation is running far too hot for where interest rates are. The question is why would you buy at these levels?" he said, adding he expected the selloff could extend to UK gilts too.
Sunday's defeat for Ishiba's Liberal Democratic Party and coalition partner Komeito follows their loss of a majority in the more powerful lower house last year. Opposition parties have advocated for tax cuts and increased government spending to help households deal with inflation.
Ishiba plans to resign, a source close to the prime minister said. Local media reported the move could happen by the end of next month. However, the prime minister later said there was no truth to the media reports about his intentions.
"Attention will soon turn to the next prime minister's policy agenda and any signals of recalibration from the BOJ as JGB yields climb," said Charu Chanana, chief investment strategist at Saxo.
After the election defeat, investors expect whoever replaces the fiscally conservative Ishiba will support calls for more government spending, widening an already bloated fiscal deficit at nearly 2-1/2 times the size of Japan's economy.
The election result also puts the Bank of Japan in a double bind as prospects of increased spending could keep inflation elevated while potentially prolonged political paralysis and the impact of the trade war provide compelling reasons to go slow on rate hikes.
"The market's first instinct was to mark up political risk premia," said Shoki Omori, chief desk strategist at Mizuho Securities, referring to reports of Ishiba's resignation.
Investors may struggle to position for the uncertainties around the multiple risks, and "consequently, the super-long sector may continue to exhibit subdued conditions through August, and possibly into September," he said.
Ten-year Japanese government bond futures tumbled as much as 1.06 yen to 137.54 yen, their lowest since March 28.
Japan's finance ministry has scaled back its issuance plan for super-long bonds in response to the surge in JGB yields and poor demand at auctions.
The central bank is due to meet again on policy next week. BOJ Deputy Governor Shinichi Uchida said that the trade deal with the U.S. reduces uncertainty, after earlier warning that economic activity and prices were skewed to the downside.
($1 = 147.0300 yen)
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
28 minutes ago
- The Independent
Trump is winning his trade war … but Americans will pay the price
President Donald Trump nabbed a major win over the weekend when he announced a trade agreement with the European Union that would slash the rate of tariffs down to 15 percent. While not the fabled ' 90 deals in 90 days ' that his trade adviser Peter Navarro had pledged when Trump initially paused his 'reciprocal tariffs,' it was still a fairly big deal given that the European Union is the biggest trading partner of the United States. And last week, Trump announced the ' largest TRADE DEAL in history ' with Japan. And a few months ago, he announced a multibillion-dollar deal with the United Kingdom. All of these countries or blocs are massive trading partners. But it didn't lead to the euphoria on Wall Street that Trump likely wanted. As of the stock market's closing bell on Monday afternoon, the S&P 500 barely budged and the Dow Jones Industrial Average dipped slightly. It might be because Americans will continue to pay more for products than they did before the deal. But one economist had another thought about the 'biggest deal ever,' as Trump alternately put it, landing with a thud. 'I also think that the markets have taken TACO a bit too seriously,' Tara Hoops, director of economic analysis at the Chamber of Progress, told The Independent. Referencing the acronym for 'Trump Always Chickens Out' — where he has gained a reputation for talking a big game regarding imposing tariffs, or in demanding ceasefires in Ukraine and Gaza, and then backing down hours or days later — Hoops said, Wall Street is in a mode 'where no one is actually believing the frameworks that are coming out.' For all of Trump's talk about how the reciprocal tariffs might lead to a renaissance of American manufacturing, Hoops flagged a fatal flaw: American auto manufacturers will pay 50 percent tariffs on steel and an additional 25 percent on other automobile parts. 'Meanwhile, the same people could just go to the EU and pass on to the consumer,' Hoops said. ' So the only person who is winning here might be Trump, because it seems to him that he has a deal, but the consumers are the ones who have to pay more for these goods.' Trump has said that the United Kingdom will know ' pretty soon ' if it will face 50-percent tariffs, but that will likely be cold comfort. And the 50-percent tariffs on European aluminum and steel will remain. Stan Veuger, a senior fellow at the conservative American Enterprise Institute, said that the European Commission started with far too much optimism about the contours of a trade deal with the United States, where they hoped there would be zero tariffs on either sides. 'I think that was really a complete misread of what the Trump administration was going to do on trade,' he told The Independent. 'It might not have been driven by naiveté but rather fear about whether the United States would uphold commitments in Ukraine and NATO. 'I think the combination of those two — just really a misread of Trump's attitudes on trade combined with those concerns about security relationships — made them not retaliate, not respond aggressively, make them not try to build an alliance with Canada and South Korea, other major American trading partners,' he added. Veuger noted that in recent months, even as Trump has paused his tariffs, the value of the dollar has gone down. 'But it's certainly not comprehensive, and also really doesn't resolve all of the trade issues that exist between the US and the EU, for example,' he said. Another unintended consequence may be that Americans might have to replace products they purchase from other countries with lower-quality products made in the United States. And Trump's rupture on tariffs means that other countries will not necessarily trust the word of an American president — because they can simply retract it the way Trump has. So far, Commerce Secretary Howard Lutnick has said that this Friday is the drop-dead date for tariffs. But this week will also show some critical tests for whether Trump puts the foot on the gas for tariffs. On Wednesday, the quarterly GDP report will drop, which will show how much the U.S. economy grew. It will be a helpful barometer because it will simultaneously show how markets reacted to the 'Liberation Day' announcements as well as the pause. That same day, the Federal Reserve will meet and make its announcement on interest rates. Trump has not been happy with Fed Chairman Jerome Powell's decision not to cut rates and he likely will keep them the same this go around as the market absorbs the rates. Lastly, on Friday, the Bureau of Labor Statistics will release its jobs report, which will again be another measurement of the health of the economy since Trump's announcement. If any of these indicators are weak, cause the stock market to nosedive or the cost of U.S. bonds to spike again, it might be time to fire up some tortillas and get ready for a fresh batch of TACO.


Reuters
29 minutes ago
- Reuters
North Korea says Trump must accept new nuclear reality
SEOUL, July 29 (Reuters) - North Korea said on Tuesday the United States must accept that reality has changed since the countries' summit meetings in the past, and no future dialogue would end its nuclear programme, state media KCNA reported. Kim Yo Jong, the powerful sister of North Korean leader Kim Jong Un who is believed to speak for his brother, said she conceded that the personal relationship between Kim and U.S. President Donald Trump "is not bad." But if Washington intended to use a personal relationship as a way to end the North's nuclear weapons programme, the effort would only be the subject of "mockery," Kim Yo Jong said in a statement carried by KCNA. "If the U.S. fails to accept the changed reality and persists in the failed past, the DPRK-U.S. meeting will remain as a 'hope' of the U.S. side," she said. DPRK is short for North Korea's official name, the Democratic People's Republic of Korea. North Korea's capabilities as a nuclear weapons state and the geopolitical environment have radically changed since Kim and Trump held talks three times during the U.S. president's first term, she said. "Any attempt to deny the position of the DPRK as a nuclear weapons state ... will be thoroughly rejected," she said. Trump has said he has a "great relationship" with Kim, and the White House has said the president is receptive to the idea of communicating with the reclusive North Korean leader.


Daily Mail
an hour ago
- Daily Mail
GSK strikes £370m deal with Chinese rival Jiangsu Hengrui to develop up to a dozen new medicines
GSK has struck a £370million deal with a Chinese rival to develop up to a dozen medicines, including a promising candidate for a chronic lung condition. The deal with Jiangsu Hengrui Pharmaceuticals comes as GSK focuses on growing its pipeline to negate declining revenues from top drugs and vaccines amid slowing demand and rising competition. Under the deal, GSK will gain an exclusive licence to Hengrui's HRS-9821, which is being studied as a treatment for chronic obstructive pulmonary disease. GSK shares rose 0.4 per cent, or 5.5p, to 1398p.